Kezar Life Sciences Inc (KZR)
0.8049
+0.01
(+1.89%)
USD |
NASDAQ |
Apr 26, 16:00
0.8024
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Cash from Investing (TTM): 76.05M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 76.05M |
September 30, 2023 | 39.51M |
June 30, 2023 | -3.775M |
March 31, 2023 | -15.47M |
December 31, 2022 | -91.39M |
September 30, 2022 | -165.22M |
June 30, 2022 | -102.03M |
March 31, 2022 | -87.29M |
December 31, 2021 | -28.44M |
September 30, 2021 | 71.36M |
June 30, 2021 | 35.67M |
March 31, 2021 | -17.86M |
December 31, 2020 | -56.50M |
Date | Value |
---|---|
September 30, 2020 | -72.14M |
June 30, 2020 | -59.30M |
March 31, 2020 | -19.89M |
December 31, 2019 | 20.42M |
September 30, 2019 | 8.825M |
June 30, 2019 | -63.47M |
March 31, 2019 | -82.73M |
December 31, 2018 | -83.90M |
September 30, 2018 | -74.05M |
June 30, 2018 | -17.71M |
March 31, 2018 | -0.584M |
December 31, 2017 | -0.389M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-165.22M
Minimum
Sep 2022
76.05M
Maximum
Dec 2023
-27.94M
Average
-19.89M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
Accuray Inc | -12.22M |
Tonix Pharmaceuticals Holding Corp | -29.07M |
Acumen Pharmaceuticals Inc | -171.67M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |